Search research articles
Contact Us
Filters
Showing results (1-10 of 52) with videos related to
Page
of 6
Sort By:
Expert Opinion on Pharmacotherapy
|
January 31, 2022
Efficacy and safety of Isavuconazole for the treatment of invasive <i>Aspergillus</i> infection - an update of the literature
Geetha Sivasubramanian, Pranatharthi H Chandrasekar
The Journal of Antimicrobial Chemotherapy
|
December 26, 2009
Safety of triazole antifungal drugs in patients with cancer
Simon Cronin, Pranatharthi H Chandrasekar
Open Forum Infectious Diseases
|
August 8, 2020
Preventing Varicella-Zoster: Advances With the Recombinant Zoster Vaccine
Sahrish Ilyas, Pranatharthi H Chandrasekar
Infectious Disease Clinics of North America
|
October 10, 2002
Bone and joint infections in injection drug users
Vivek Kak, Pranatharthi H Chandrasekar
Expert Opinion on Pharmacotherapy
|
June 15, 2021
Azole resistance in <i>Aspergillus</i> species: promising therapeutic options
Shirisha Pasula, Pranatharthi H Chandrasekar
Chest
|
June 18, 2002
The clinical spectrum of pulmonary aspergillosis
Ayman O Soubani, Pranatharthi H Chandrasekar
Clinical Transplantation
|
September 2, 2016
Adverse effects of voriconazole: Over a decade of use
Miriam T Levine, Pranatharthi H Chandrasekar
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America
|
April 6, 2005
Amphotericin B lipid complex in the management of invasive aspergillosis in immunocompromised patients
Pranatharthi H Chandrasekar, James I Ito
Expert Review of Clinical Pharmacology
|
November 25, 2011
Antifungal drugs: predicting clinical efficacy with pharmacodynamics
Michael D Nailor, Pranatharthi H Chandrasekar
Drugs
|
February 9, 2008
Current and future therapeutic options in the management of invasive aspergillosis
Suganthini Krishnan-Natesan, Pranatharthi H Chandrasekar
Page
of 6
Search research articles
Search
Showing results (1-10 of 52) with videos related to
Sort By:
Page
of 6
Expert Opinion on Pharmacotherapy
|
January 31, 2022
Efficacy and safety of Isavuconazole for the treatment of invasive <i>Aspergillus</i> infection - an update of the literature
Geetha Sivasubramanian, Pranatharthi H Chandrasekar
The Journal of Antimicrobial Chemotherapy
|
December 26, 2009
Safety of triazole antifungal drugs in patients with cancer
Simon Cronin, Pranatharthi H Chandrasekar
Open Forum Infectious Diseases
|
August 8, 2020
Preventing Varicella-Zoster: Advances With the Recombinant Zoster Vaccine
Sahrish Ilyas, Pranatharthi H Chandrasekar
Infectious Disease Clinics of North America
|
October 10, 2002
Bone and joint infections in injection drug users
Vivek Kak, Pranatharthi H Chandrasekar
Expert Opinion on Pharmacotherapy
|
June 15, 2021
Azole resistance in <i>Aspergillus</i> species: promising therapeutic options
Shirisha Pasula, Pranatharthi H Chandrasekar
Chest
|
June 18, 2002
The clinical spectrum of pulmonary aspergillosis
Ayman O Soubani, Pranatharthi H Chandrasekar
Clinical Transplantation
|
September 2, 2016
Adverse effects of voriconazole: Over a decade of use
Miriam T Levine, Pranatharthi H Chandrasekar
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America
|
April 6, 2005
Amphotericin B lipid complex in the management of invasive aspergillosis in immunocompromised patients
Pranatharthi H Chandrasekar, James I Ito
Expert Review of Clinical Pharmacology
|
November 25, 2011
Antifungal drugs: predicting clinical efficacy with pharmacodynamics
Michael D Nailor, Pranatharthi H Chandrasekar
Drugs
|
February 9, 2008
Current and future therapeutic options in the management of invasive aspergillosis
Suganthini Krishnan-Natesan, Pranatharthi H Chandrasekar
Page
of 6